Form 4: Lucid Diagnostics Inc. Executive Receives 400,000 Shares of Restricted Stock

Sentiment:

SEC Form 4 Filing


Michael Adam Gordon, General Counsel and Secretary of Lucid Diagnostics Inc., acquired 400,000 shares of restricted stock on May 7, 2024, under the company's 2018 Equity Plan.

Summary

  • Michael Adam Gordon, the General Counsel and Secretary of Lucid Diagnostics Inc., filed a Form 4 on May 7, 2024, reporting a transaction.
  • He acquired 400,000 shares of Lucid Diagnostics Inc. common stock.
  • These shares were granted as restricted stock under the Issuer's 2018 Equity Plan.
  • The restricted stock has a single vesting date of May 20, 2026, and is subject to forfeiture if the required service period isn't completed.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The grant of restricted stock is a standard practice and indicates confidence in the executive and the company's future.

Positives

  • The grant of restricted stock aligns the executive's interests with the long-term performance of the company.
  • The vesting schedule encourages continued service and commitment from the executive.

Risks

  • The restricted stock is subject to forfeiture if the service period is not completed, which could impact the executive's motivation if circumstances change.

Future Outlook

The document does not contain any specific forward-looking statements or guidance.

Industry Context

This type of equity grant is a common practice in publicly traded companies to incentivize and retain key executives.

Comparison to Industry Standards

  • Equity grants are a standard component of executive compensation packages in the diagnostics industry.
  • Companies like Exact Sciences and Guardant Health also utilize stock options and restricted stock units to align executive incentives with shareholder value.
  • The vesting schedule of May 20, 2026, is a typical timeframe for such grants, ensuring long-term commitment.

Stakeholder Impact

  • Shareholders may view the equity grant positively as it aligns executive interests with company performance.
  • Employees may see it as a sign of stability and commitment to leadership.

Key Dates

DateDescription
05/07/2024Date of transaction: Michael Adam Gordon acquired 400,000 shares of restricted stock.
05/07/2024Date of Form 4 filing.
05/20/2026Vesting date for the restricted stock.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.